Purdue Pharma's sentencing in opioids case is imminent, clearing the way for settlement money to flow
Briefly

Purdue Pharma's sentencing in opioids case is imminent, clearing the way for settlement money to flow
"Purdue Pharma pleaded guilty to three federal criminal charges in November 2020, admitting it lacked an effective program to prevent its prescription painkillers from being diverted to the black market."
"The company acknowledged paying doctors through a speakers program to prescribe opioids and incentivizing an electronic medical records company to encourage more prescriptions."
"While Purdue produced only a fraction of the opioid pills that flooded the market, its aggressive sales of OxyContin have been seen as a key factor in the opioid crisis."
"The government agreed not to collect $5.3 billion in criminal forfeitures and $2.8 billion in civil liabilities as part of the plea deal, allowing Purdue to settle other lawsuits."
Purdue Pharma is expected to forfeit $225 million to the Justice Department, finalizing a settlement related to thousands of lawsuits over the opioid crisis. This penalty is part of a 2020 agreement to resolve federal investigations. The Sackler family will pay up to $7 billion to various governments and victims. Purdue admitted to failing to prevent opioid diversion and incentivizing doctors to prescribe more opioids. The settlement also includes waiving $5.3 billion in criminal forfeitures and $2.8 billion in civil liabilities.
Read at Fast Company
Unable to calculate read time
[
|
]